A

Aileen I. Fernandez

Yale University

ORCID: 0000-0001-7442-6635

Publishes on Cancer Immunotherapy and Biomarkers, PARP inhibition in cancer therapy, Head and Neck Cancer Studies. 181 papers and 1.2k citations.

PubIndex Score97Top 3% · mid-careerHow it's scored

🔥#1 Rising Star in HER2/EGFR in Cancer Research

181Publications

1.2kTotal Citations

#1in HER2/EGFR in Cancer Research

First publication: 2023First senior author: 2023

Cancer Immunotherapy and Biomarkers PARP inhibition in cancer therapy Head and Neck Cancer Studies HER2/EGFR in Cancer Research Radiomics and Machine Learning in Medical Imaging

Top publicationsby citations

Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue

Aileen I. Fernandez, David L. Rimm, Matthew Liu et al.|JAMA Oncology|2022

Cited by 347

Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer

Saman Farahmand, Kourosh Zarringhalam, Aileen I. Fernandez et al.|Modern Pathology|2021

Cited by 166

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Myrto Moutafi, David L. Rimm, Charles T. Robbins et al.|Laboratory Investigation|2022

Cited by 141

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

Charles T. Robbins, David L. Rimm, Aileen I. Fernandez et al.|Modern Pathology|2023

Cited by 98

Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial Profiling

Myrto Moutafi, David L. Rimm, Sandra Martínez-Morilla et al.|Journal of Thoracic Oncology|2022

Cited by 40